Evolving concepts in the management of hepatocellular carcinoma: from 'stage hierarchy' to the 'multiparametric therapeutic hierarchy' approach.
作者信息
Rondé-Roupie Charlotte, Tzedakis Stylianos
机构信息
Department of Digestive, Pancreatic, Hepato-biliary and Endocrine Surgery, Cochin Hospital, APHP, University of Paris, Paris, France.
出版信息
Hepatobiliary Surg Nutr. 2025 Feb 1;14(1):118-120. doi: 10.21037/hbsn-2024-652. Epub 2025 Jan 9.
Abstract
摘要
相似文献
1
Evolving concepts in the management of hepatocellular carcinoma: from 'stage hierarchy' to the 'multiparametric therapeutic hierarchy' approach.肝细胞癌管理中的概念演变：从“分期层级”到“多参数治疗层级”方法
Hepatobiliary Surg Nutr. 2025 Feb 1;14(1):118-120. doi: 10.21037/hbsn-2024-652. Epub 2025 Jan 9.
2
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.肝硬化合并孤立性大肝细胞癌患者行肝切除与射频消融联合经动脉化疗栓塞术的比较
J Vasc Interv Radiol. 2017 Nov;28(11):1512-1519. doi: 10.1016/j.jvir.2017.06.016. Epub 2017 Jul 19.
3
Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.巴塞罗那临床肝癌分期0/A期切除术后复发性肝细胞癌经动脉化疗栓塞术与射频消融术的回顾性对比研究
J Vasc Interv Radiol. 2016 Dec;27(12):1829-1836. doi: 10.1016/j.jvir.2016.06.010. Epub 2016 Aug 21.
4
Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma.多结节BCLC-A期肝细胞癌患者肝切除与经动脉化疗栓塞的疗效
J Liver Cancer. 2024 Sep;24(2):178-191. doi: 10.17998/jlc.2024.03.25. Epub 2024 Apr 3.
5
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma.早期多结节性肝细胞癌患者的肝切除术与非手术治疗。
JAMA Surg. 2024 Aug 1;159(8):881-889. doi: 10.1001/jamasurg.2024.1184.
6
Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome.经动脉化疗栓塞联合射频消融治疗肝细胞癌：两种治疗方法之间时间间隔对疗效的影响。
J Vasc Interv Radiol. 2019 Dec;30(12):1879-1886. doi: 10.1016/j.jvir.2019.07.029. Epub 2019 Oct 24.
7
Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.肝细胞癌治疗中联合疗法的比较：经动脉化疗栓塞联合射频消融与微波消融
J Vasc Interv Radiol. 2015 Mar;26(3):330-41. doi: 10.1016/j.jvir.2014.10.047. Epub 2014 Dec 18.
8
A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma.肝细胞癌图像引导下局部区域治疗的最新进展
Gastrointest Tumors. 2016 Oct;3(2):90-102. doi: 10.1159/000445888. Epub 2016 Apr 28.
9
Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.晚期肝细胞癌行肝切除术是否合理？464例患者的观察性研究结果
J Gastrointest Surg. 2009 Jul;13(7):1313-20. doi: 10.1007/s11605-009-0903-x. Epub 2009 May 6.
10
Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment.射频消融联合经动脉化疗栓塞治疗巴塞罗那临床肝癌分期A期不可治愈性肝细胞癌患者的疗效与安全性
Korean J Gastroenterol. 2019 Mar 25;73(3):167-176. doi: 10.4166/kjg.2019.73.3.167.
本文引用的文献
1
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma.早期多结节性肝细胞癌患者的肝切除术与非手术治疗。
JAMA Surg. 2024 Aug 1;159(8):881-889. doi: 10.1001/jamasurg.2024.1184.
2
Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis.肝切除术与射频消融或经动脉化疗栓塞治疗早期（BCLC A）寡结节性肝细胞癌的比较：荟萃分析。
BJS Open. 2024 Jan 3;8(1). doi: 10.1093/bjsopen/zrad158.
3
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept.肝细胞癌患者的个性化管理：一种多参数治疗分级概念
Lancet Oncol. 2023 Jul;24(7):e312-e322. doi: 10.1016/S1470-2045(23)00186-9.
4
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌预防、诊断和治疗实践指南。
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
5
Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria.米兰标准内多发性小肝细胞癌肝切除、射频消融和经动脉治疗的疗效比较。
Ann Surg Treat Res. 2020 Oct;99(4):238-246. doi: 10.4174/astr.2020.99.4.238. Epub 2020 Sep 24.
6
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study.肝细胞癌患者治疗层级的概念：一项多中心队列研究。
Liver Int. 2019 Aug;39(8):1478-1489. doi: 10.1111/liv.14154. Epub 2019 Jun 26.
7
Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey.肝切除术治疗多发性肝细胞癌：一项日本全国性调查。
Ann Surg. 2020 Jul;272(1):145-154. doi: 10.1097/SLA.0000000000003192.
8
Radiofrequency ablation versus surgical resection for multiple HCCs meeting the Milan criteria: propensity score analyses of 10-year therapeutic outcomes.符合米兰标准的多发性肝癌的射频消融与手术切除：10年治疗结果的倾向评分分析
Clin Radiol. 2018 Jul;73(7):676.e15-676.e24. doi: 10.1016/j.crad.2018.02.007. Epub 2018 Apr 27.
9
Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma within Milan criteria: A propensity score matching analysis.米兰标准内肝细胞癌的肝切除术或经动脉化疗栓塞术：一项倾向评分匹配分析。
Medicine (Baltimore). 2017 Dec;96(51):e8933. doi: 10.1097/MD.0000000000008933.
10
Comparison of Outcomes of Hepatic Resection and Radiofrequency Ablation for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the Barcelona-Clinic Liver Cancer Stage A Classification.符合巴塞罗那临床肝癌分期A类标准的多灶性肿瘤肝细胞癌患者肝切除与射频消融治疗效果的比较
J Am Coll Surg. 2015 Nov;221(5):951-61. doi: 10.1016/j.jamcollsurg.2015.08.009. Epub 2015 Aug 20.
Zotero 插件